OpenURL Connection Search

Select item for more details and to access through your institution.

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
Published in:
Investigational New Drugs, 2018, v. 36, n. 5, p. 828, doi. 10.1007/s10637-017-0551-z
By:
- van der Biessen, Diane A. J.;
- Gietema, Jourik A.;
- de Jonge, Maja J. A.;
- Desar, Ingrid M. E.;
- den Hollander, Martha W.;
- Dudley, Matthew;
- Dunbar, Martin;
- Hetman, Robert;
- Serpenti, Camille;
- Xiong, Hao;
- Mittapalli, Rajendar K.;
- Timms, Kirsten M.;
- Ansell, Peter;
- Ratajczak, Christine K.;
- Shepherd, Stacie Peacock;
- van Herpen, Carla M. L.
Publication type:
Article
A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies.
Published in:
Clinical Colorectal Cancer, 2015, v. 14, n. 1, p. 18, doi. 10.1016/j.clcc.2014.12.001
By:
- Oldenhuis, Corina N.;
- Loos, Walter J.;
- Esteves, Brooke;
- van Doom, Leni;
- Cotreau, Monette M.;
- Strahs, Andrew L.;
- den Hollander, Martha W.;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.;
- Eskens, Ferry A. L. M.
Publication type:
Article
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1310, doi. 10.2967/jnumed.115.154401
By:
- den Hollander, Martha W.;
- Bensch, Frederike;
- Glaudemans, Andor W. J. M.;
- Munnink, Thijs H. Oude;
- Enting, Roelien H.;
- den Dunnen, Wilfred F. A.;
- Heesters, Mart A. A. M.;
- Kruyt, Frank A. E.;
- Lub-de Hooge, Marjolijn N.;
- de Groot, Jan Cees;
- Pearlberg, Joseph;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.;
- Walenkamp, Annemiek M. E.
Publication type:
Article
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 13, p. 2404, doi. 10.1007/s00259-018-4090-4
By:
- den Hollander, Martha W.;
- de Vries, Elisabeth G. E.;
- Walenkamp, Annemiek M. E.;
- Brahm, Cyrillo G.;
- Verheul, Henk M. W.;
- Enting, Roelien H.;
- de Groot, Jan Cees;
- Solouki, A. Millad;
- den Dunnen, Wilfred F. A.;
- Heesters, Mart A. A. M.;
- Wagemakers, Michiel;
- Pruim, Jan
Publication type:
Article

Found: 4

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.

A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies.

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET.

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.